FLOORTJE BACKES

Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology HILLIARD, OH NPI 1124231998

General Payments — all program years on this page

$164,246.47

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 160
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $48,257.61 across 38 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $39,751.1913
Travel and Lodging $7,444.308
Food and Beverage $1,062.1217

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
BioNTech SE $13,617.5510
Merck Sharp & Dohme Corporation $12,851.118
Acerta Pharma LLC $8,247.624
GlaxoSmithKline, LLC. $7,039.837
EISAI INC. $2,509.002
EMD Serono Research & Development Institute, Inc. $2,130.001
ImmunoGen, Inc. $1,479.002
Karyopharm Therapeutics Inc. $193.262
PFIZER INC. $134.901
ABBVIE INC. $55.341

By program year

Program yearAmountRecords
2018 $12,053.7024
2019 $21,406.2633
2020 $21,954.6024
2021 $15,001.968
2022 $19,742.0013
2023 $25,830.3420
2024 $48,257.6138

Records — PY2024 (38)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1099941373 ImmunoGen, Inc. $79.00 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1099941375 ImmunoGen, Inc. $1,400.00 01/26/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1103260763 ABBVIE INC. $55.34 09/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104342758 AstraZeneca Pharmaceuticals LP $1,370.00 12/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1105434255 AstraZeneca Pharmaceuticals LP $27.62 03/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105457408 AstraZeneca Pharmaceuticals LP $3,425.00 01/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1105630497 AstraZeneca Pharmaceuticals LP $3,425.00 03/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1110745608 Eisai Inc. $2,445.00 04/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1110745610 Eisai Inc. $64.00 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115825113 GlaxoSmithKline, LLC. $24.43 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116234233 GlaxoSmithKline, LLC. $123.60 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116422095 GlaxoSmithKline, LLC. $2,800.00 02/22/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1116433511 GlaxoSmithKline, LLC. $1,600.00 01/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1116517046 GlaxoSmithKline, LLC. $28.00 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116545270 GlaxoSmithKline, LLC. $2,416.19 11/06/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1116688714 GlaxoSmithKline, LLC. $47.61 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120275442 EMD Serono Research & Development Institute, Inc. $2,130.00 01/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1131356923 PFIZER INC. $134.90 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141570024 Merck Sharp & Dohme LLC $150.00 11/18/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141570026 Merck Sharp & Dohme LLC $6,710.00 11/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141570028 Merck Sharp & Dohme LLC $4,880.00 10/28/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141688154 Merck Sharp & Dohme LLC $335.83 11/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141688244 Merck Sharp & Dohme LLC $136.25 11/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141688246 Merck Sharp & Dohme LLC $545.05 11/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141867033 Merck Sharp & Dohme LLC $48.00 11/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141867035 Merck Sharp & Dohme LLC $45.98 11/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145529723 Karyopharm Therapeutics Inc. $50.00 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145529726 Karyopharm Therapeutics Inc. $143.26 06/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150660304 BioNTech SE $22.84 09/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1150660306 BioNTech SE $64.00 02/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1150660308 BioNTech SE $5,925.00 02/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1150660310 BioNTech SE $265.33 02/03/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1150660384 BioNTech SE $74.25 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150660386 BioNTech SE $79.71 02/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150660388 BioNTech SE $17.27 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150660390 BioNTech SE $19.15 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150660496 BioNTech SE $3,250.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1150660498 BioNTech SE $3,900.00 02/23/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.